{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-010308","form_type":"8-K","ticker":"CELC","cik":"0001603454","company_name":"Celcuity Inc.","filed_at":"2025-05-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.976729+00:00","generated_at":"2026-05-21T08:47:44.643176+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Celcuity reports Q1 net loss $37.0M; VIKTORIA-1 WT data expected Q3 2025","bullets":["Net loss of $37.0M ($0.86/sh) vs $21.6M ($0.64/sh) in Q1 2024; non-GAAP adj. net loss $34.7M ($0.81/sh).","Cash, cash equivalents and investments of ~$206M at March 31, 2025, expected to fund operations through 2026.","VIKTORIA-1 PIK3CA wild-type cohort topline data now anticipated in Q3 2025; mutant cohort data in Q4 2025.","VIKTORIA-2 Phase 3 first patient dosing on track for Q2 2025; CELC-G-201 Phase 1b data expected late Q2 2025.","Clinical trial collaboration initiated with Dana Farber and Mass General for gedatolisib in endometrial cancer."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-010308","json":"https://secwatch.observer/filing/0001641172-25-010308.json","markdown":"https://secwatch.observer/filing/0001641172-25-010308.md","text":"https://secwatch.observer/filing/0001641172-25-010308.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1603454/000164117225010308/0001641172-25-010308-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1603454/000164117225010308/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T08:47:44.643176+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}